Hospital Pharmacist's Letter | Trusted CE & Recommendations

October 2023 Issue

Use a Conservative Approach for Most Inpatient Hypertension

You’ll get questions about how to manage blood pressure elevations during a hospitalization...

Resources

Checklist: Acute Ischemic Stroke Pharmacotherapy Checklist
FAQ: Management of Severe Hypertension in Adults

Look for a New Injectable Buprenorphine for OUD

Brixadi will join Sublocade as the second long-acting injectable buprenorphine for moderate to severe opioid use disorder (OUD)...

Think of the “ABCDS” When Managing Chronic Coronary Disease

You’ll get questions about managing chronic coronary disease...

Be Ready to Treat Tumor Lysis Syndrome

You’ll need to be prepared to manage tumor lysis syndrome (TLS)...

GO TO FULL ISSUE

CE & Training

PODCAST: RSV Vaccines in Older Adults

CE-IN-THE-LETTER: Hospital Pharmacist's Letter October 2023

LIVE CE: Pharmacy Essential Updates October 2023

SELF-STUDY CE: Non-Opioid Pain Management

GO TO CE & TRAINING ORGANIZER >

Free Clinical Resources

Management of Acute Agitation and Delirium in Adults

COVID-19 Treatments of Interest

Treatment of Acute Pain in Opioid Use Disorder

GO TO ALL CLINICAL RESOURCES >

What is Hospital Pharmacist's Letter?

Pharmacist's Letter is the resource trusted by over 200,000 pharmacists for staying current on medication recommendations and taking and tracking CE. Learn more >

Developing Your Pharmacy Career

Hospital Pharmacist's Letter is one of many CE and training solutions from TRC Healthcare. We support pharmacists like you at all stages of their career. Learn more about our: